Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Xolair® (omalizumab)

Dupilumab Shows Promise for Patients Struggling With OIT Side Effects

Omalizumab as Effective as Oral Immunotherapy for Multiple Allergens According to...

GSK’s $2.2 Billion Acquisition of Rapt Signals a New Era for...

A new era in food allergy treatment has begun

Asthma drug shows promise in blocking food allergy reactions

Study Suggests Biologics Safe to Recommend for Treatment of IgE-Mediated Food...

Insurance Change Jeopardizes 12-Year-Old’s Xolair Treatment

A Conversation About Mia, a 9-Year-Old Undergoing Xolair Therapy for Food...

Omalizumab (Xolair) Is Superior to Oral Immunotherapy in Multi-Food Allergy Treatment

FDA Approves LongBio’s Anti-IgE Antibody for Clinical Trials to Treat Food...

Follow Us

Your School On Our Map

Put Your School on the Map